Literature DB >> 32389710

Updated risk factors to inform early pancreatic cancer screening and identify high risk patients.

Daniel R Principe1, Ajay Rana2.   

Abstract

Pancreatic adenocarcinoma (PDAC) is associated with poor clinical outcomes and incomplete responses to conventional therapy. Therefore, there is an unmet clinical need to better understand the predisposing factors for pancreatic cancer in hopes of providing early screening to high-risk patients. While select risk factors such as age, race, and family history, or predisposing syndromes are unavoidable, there are several new and established risk factors that allow for intervention, namely by counseling patients to make the appropriate lifestyle modifications. Here, we discuss the best-studied risk factors for PDAC such as tobacco use and chronic pancreatitis, as well as newly emerging risk factors including select nutritional deficits, bacterial infections, and psychosocial factors. As several of these risk factors appear to be additive or synergistic, by understanding their relationships and offering coordinated, multidisciplinary care to high-risk patients, it may be possible to reduce pancreatic cancer incidence and improve clinical outcomes through early detection.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer prevention; Cancer risk factors; Cancer screening; Pancreatic cancer

Mesh:

Year:  2020        PMID: 32389710      PMCID: PMC7313672          DOI: 10.1016/j.canlet.2020.04.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   9.756


  178 in total

Review 1.  Peutz-Jeghers syndrome and screening for pancreatic cancer.

Authors:  A Latchford; W Greenhalf; L J Vitone; J P Neoptolemos; G A Lancaster; R K S Phillips
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

Review 2.  Tobacco and the risk of pancreatic cancer: a review and meta-analysis.

Authors:  Simona Iodice; Sara Gandini; Patrick Maisonneuve; Albert B Lowenfels
Journal:  Langenbecks Arch Surg       Date:  2008-01-12       Impact factor: 3.445

Review 3.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

4.  A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Shu-Chun Chuang; Rachael Stolzenberg-Solomon; Per Magne Ueland; Stein Emil Vollset; Øivind Midttun; Anja Olsen; Anne Tjønneland; Kim Overvad; Marie-Christine Boutron-Ruault; Sophie Morois; Françoise Clavel-Chapelon; Birgit Teucher; Rudolf Kaaks; Cornelia Weikert; Heiner Boeing; Antonia Trichopoulou; Vassiliki Benetou; Androniki Naska; Mazda Jenab; Nadia Slimani; Isabelle Romieu; Dominique S Michaud; Domenico Palli; Sabina Sieri; Salvatore Panico; Carlotta Sacerdote; Rosario Tumino; Guri Skeie; Eric J Duell; Laudina Rodriguez; Esther Molina-Montes; José Marı A Huerta; Nerea Larrañaga; Aurelio Barricarte Gurrea; Dorthe Johansen; Jonas Manjer; Weimin Ye; Malin Sund; Petra H M Peeters; Suzanne Jeurnink; Nicholas Wareham; Kay-Tee Khaw; Francesca Crowe; Elio Riboli; Bas Bueno-de-Mesquita; Paolo Vineis
Journal:  Eur J Cancer       Date:  2011-03-14       Impact factor: 9.162

5.  Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus.

Authors:  Phil A Hart; Esha Baichoo; Yan Bi; Alice Hinton; Yogish C Kudva; Suresh T Chari
Journal:  Pancreatology       Date:  2015-02-24       Impact factor: 3.996

6.  ABO blood group and the risk of pancreatic cancer.

Authors:  Brian M Wolpin; Andrew T Chan; Patricia Hartge; Stephen J Chanock; Peter Kraft; David J Hunter; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

7.  Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.

Authors:  Kirsten L Bryant; Clint A Stalnecker; Daniel Zeitouni; Jennifer E Klomp; Sen Peng; Andrey P Tikunov; Venugopal Gunda; Mariaelena Pierobon; Andrew M Waters; Samuel D George; Garima Tomar; Björn Papke; G Aaron Hobbs; Liang Yan; Tikvah K Hayes; J Nathaniel Diehl; Gennifer D Goode; Nina V Chaika; Yingxue Wang; Guo-Fang Zhang; Agnieszka K Witkiewicz; Erik S Knudsen; Emanuel F Petricoin; Pankaj K Singh; Jeffrey M Macdonald; Nhan L Tran; Costas A Lyssiotis; Haoqiang Ying; Alec C Kimmelman; Adrienne D Cox; Channing J Der
Journal:  Nat Med       Date:  2019-03-04       Impact factor: 53.440

8.  Pancreatic cancer susceptibility loci and their role in survival.

Authors:  Cosmeri Rizzato; Daniele Campa; Nathalia Giese; Jens Werner; P Sivaramakrishna Rachakonda; Rajiv Kumar; Michaela Schanné; William Greenhalf; Eithne Costello; Kay-Tee Khaw; Tim J Key; Afshan Siddiq; Justo Lorenzo-Bermejo; Barbara Burwinkel; John P Neoptolemos; Markus W Büchler; Jörg D Hoheisel; Andrea Bauer; Federico Canzian
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

9.  Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Authors:  Brian M Wolpin; Cosmeri Rizzato; Peter Kraft; Charles Kooperberg; Gloria M Petersen; Zhaoming Wang; Alan A Arslan; Laura Beane-Freeman; Paige M Bracci; Julie Buring; Federico Canzian; Eric J Duell; Steven Gallinger; Graham G Giles; Gary E Goodman; Phyllis J Goodman; Eric J Jacobs; Aruna Kamineni; Alison P Klein; Laurence N Kolonel; Matthew H Kulke; Donghui Li; Núria Malats; Sara H Olson; Harvey A Risch; Howard D Sesso; Kala Visvanathan; Emily White; Wei Zheng; Christian C Abnet; Demetrius Albanes; Gabriella Andreotti; Melissa A Austin; Richard Barfield; Daniela Basso; Sonja I Berndt; Marie-Christine Boutron-Ruault; Michelle Brotzman; Markus W Büchler; H Bas Bueno-de-Mesquita; Peter Bugert; Laurie Burdette; Daniele Campa; Neil E Caporaso; Gabriele Capurso; Charles Chung; Michelle Cotterchio; Eithne Costello; Joanne Elena; Niccola Funel; J Michael Gaziano; Nathalia A Giese; Edward L Giovannucci; Michael Goggins; Megan J Gorman; Myron Gross; Christopher A Haiman; Manal Hassan; Kathy J Helzlsouer; Brian E Henderson; Elizabeth A Holly; Nan Hu; David J Hunter; Federico Innocenti; Mazda Jenab; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Eric A Klein; Manolis Kogevinas; Vittorio Krogh; Juozas Kupcinskas; Robert C Kurtz; Andrea LaCroix; Maria T Landi; Stefano Landi; Loic Le Marchand; Andrea Mambrini; Satu Mannisto; Roger L Milne; Yusuke Nakamura; Ann L Oberg; Kouros Owzar; Alpa V Patel; Petra H M Peeters; Ulrike Peters; Raffaele Pezzilli; Ada Piepoli; Miquel Porta; Francisco X Real; Elio Riboli; Nathaniel Rothman; Aldo Scarpa; Xiao-Ou Shu; Debra T Silverman; Pavel Soucek; Malin Sund; Renata Talar-Wojnarowska; Philip R Taylor; George E Theodoropoulos; Mark Thornquist; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Pavel Vodicka; Jean Wactawski-Wende; Nicolas Wentzensen; Chen Wu; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Robert Hoover; Patricia Hartge; Charles Fuchs; Stephen J Chanock; Rachael S Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Nat Genet       Date:  2014-08-03       Impact factor: 41.307

10.  Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese.

Authors:  Makoto Ueno; Shinichi Ohkawa; Manabu Morimoto; Hiroshi Ishii; Masato Matsuyama; Sawako Kuruma; Naoto Egawa; Haruhisa Nakao; Mitsuru Mori; Keitaro Matsuo; Satoyo Hosono; Masanori Nojima; Kenji Wakai; Kozue Nakamura; Akiko Tamakoshi; Mami Takahashi; Kazuaki Shimada; Takeshi Nishiyama; Shogo Kikuchi; Yingsong Lin
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

View more
  6 in total

Review 1.  Trials and tribulations of pancreatic cancer immunotherapy.

Authors:  Daniel R Principe; Murray Korc; Suneel D Kamath; Hidayatullah G Munshi; Ajay Rana
Journal:  Cancer Lett       Date:  2021-02-04       Impact factor: 9.756

2.  Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1.

Authors:  Qian Yu; Zhong Zhang; Haijun Zhang
Journal:  Cancer Manag Res       Date:  2021-02-11       Impact factor: 3.989

Review 3.  Precision Medicine for BRCA/PALB2-Mutated Pancreatic Cancer and Emerging Strategies to Improve Therapeutic Responses to PARP Inhibition.

Authors:  Daniel R Principe
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

Review 4.  Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.

Authors:  Silviu Stanciu; Florentina Ionita-Radu; Constantin Stefani; Daniela Miricescu; Iulia-Ioana Stanescu-Spinu; Maria Greabu; Alexandra Ripszky Totan; Mariana Jinga
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

5.  Synergistic Analysis of Circulating Tumor Cells Reveals Prognostic Signatures in Pilot Study of Treatment-Naïve Metastatic Pancreatic Cancer Patients.

Authors:  Sarah Owen; Emily Prantzalos; Valerie Gunchick; Vaibhav Sahai; Sunitha Nagrath
Journal:  Biomedicines       Date:  2022-01-11

Review 6.  The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.

Authors:  Daniel R Principe; Patrick W Underwood; Murray Korc; Jose G Trevino; Hidayatullah G Munshi; Ajay Rana
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.